webinar register page

BioLineRx KOL Webinar: Final Results from Phase 2a COMBAT/KEYNOTE-202 Triple Combination Study of Motixafortide in Second Line Metastatic Pancreatic Cancer (PDAC)

00:54:00

Dec 16, 2020 07:40 AM

* Required information
Loading